Cardiovascular Risk in Women With Nonclassical Congenital Adrenal Hyperplasia
Authors:
- Fernanda Cavalieri CostaFCFernanda Cavalieri Costa
- Larissa Garcia GomesLGLarissa Garcia Gomes
- Thais Martins de LimaTLThais Martins de Lima
- Luiz Aparecido BortolottoLBLuiz Aparecido Bortolotto
- Valeria HongVHValeria Hong
- Renata VerardinoRVRenata Verardino
- Manoel de Souza RochaMRManoel de Souza Rocha
- Serli Kiyomi Nakao UedaSUSerli Kiyomi Nakao Ueda
- Mirela Costa de MirandaMMMirela Costa de Miranda
- Heraldo Possolo de SouzaHSHeraldo Possolo de Souza
- Ana Claudia LatronicoALAna Claudia Latronico
- Berenice Bilharinho MendoncaBMBerenice Bilharinho Mendonca
Open Access
- 11 March 2024
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 110 (1) , e72-e79
Abstract
Context The outcomes related to cardiovascular risk (CVR) in patients with nonclassical form of congenital adrenal hyperplasia (NCAH) are unknown, especially those related to therapeutic options, including low doses of glucocorticoids (GCs) or oral contraceptive pills. Objectives to analyze CVR by markers of atherosclerosis in females with nonclassical form according to therapeutic options. Design and Setting a cross-sectional study at a tertiary center. Patients and Methods Forty-seven females with NCAH (33.4 ± 10 years) were subdivided into: G1 (n = 28) treated with dexamethasone (0.14 ± 0.05 mg/m2/day); G2 (n = 19) with oral contraceptive pills; and G3 (30 matched controls). CVR was analyzed through serum lipids, HOMA-IR, inflammatory cytokines levels and quantitative image evaluations (pulse wave velocity-PWV, endothelial function by flow mediated dilatation-FMD, carotid intima media thickness-CIMT and visceral fat-VAT by abdominal tomography. Results There were no statistically significant differences in BMI, HOMA-IR, HDL-cholesterol, or triglyceride levels among groups (p > 0.05). Serum interleukin-6 levels were higher in G1 than in G2 (p = 0.048), and interleukin-8 levels were higher in G1 than in G2/3 (p = 0.008). There were no statistically significant differences in VAT, PWV, FMD or CIMT among groups (p > 0.05). In multivariable regression analysis, there was no statistically significant association between glucocorticoid dose and evaluated outcomes. Conclusion Adult females with NCAH did not show increased CVR using methodologies for detection of precocious atherosclerosis. Although patients receiving dexamethasone therapy had increased IL-6 and 8 levels, these data were not associated with radiological markers of atherosclerosis. Our cohort was composed of young adults and should be reevaluated in a long-term follow-up.Keywords
Funding Information
- FAPESP (2019/26780-9.)
- CNPq (308871/2022-7)
This publication has 36 references indexed in Scilit:
- Association between vascular endothelial dysfunction and the inflammatory marker neopterin in patients with classic congenital adrenal hyperplasiaAtherosclerosis, 2021
- Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiencyThe Journal of Steroid Biochemistry and Molecular Biology, 2020
- Relation between age and carotid artery intima‐medial thickness: a systematic reviewClinical Cardiology, 2018
- Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiencyEuropean Journal of Pediatrics, 2017
- Assessment and Prognosis of Peripheral Artery Measures of Vascular FunctionProgress in Cardiovascular Diseases, 2015
- Erratum to: Increased large artery intima media thickness in adolescents with either classical or non-classical congenital adrenal hyperplasiaJournal of Endocrinological Investigation, 2013
- Metabolic disorders in newly diagnosed young adult female patients with simple virilizing 21-hydroxylase deficiencyEndocrine, 2010
- Prediction of Cardiovascular Events and All-Cause Mortality With Arterial StiffnessJACC, 2010
- Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular diseaseJACC, 2003
- Receptor-mediated effects of glucocorticoids on inflammation: Enhancement of the inflammatory response with a glucocorticoid antagonistThe Journal of Steroid Biochemistry and Molecular Biology, 1988